Indian authorities are investigating more than 12 pharmaceutical firms suspected of illegally exporting pseudoephedrine to Myanmar and China. At least one of the suspects owns drug manufacturing plants in India.
Published in Brief:
|Compliance and Ethics Director||
Sysmex America, Inc.
|Director, Site Quality Management||
|Palm Springs, CA|
|Compliance Officer-Medical Products||
W. L. Gore